COVID-19: Vaccines and Therapeutics
In this conversation, Nancy Foster, Vice President for Quality and Patient Safety Policy, talks with Sonia Perez, Chief Operating Officer, UnidosUS, and Clint Odom, Senior Vice President, Policy & Advocacy, National Urban League and Executive Director, National Urban League’s Washington Bureau…
As a physician, nurse, respiratory therapist, environmental services or food services worker or other health care professional, your example is one of the strongest health resources we have. When you get your COVID-19 vaccine, please consider sharing your story to help others understand the…
Special Bulletin
The Food and Drug Administration (FDA) last week granted an emergency use authorization (EUA) to Pfizer, Inc. for its BNT162b2 mRNA COVID-19 vaccine. As you are aware, distribution and administration of the first shipments are well underway across the country.
The Centers for Disease Control and Prevention will award states and territories another $227 million in funding from the Coronavirus Aid, Relief, and Economic Security Act and Paycheck Protection Program and Health Care Enhancement Act for COVID-19 vaccine preparedness and complementary activities…
In an open letter, the AHA, American Medical Association and American Nurses Association thanked health care professionals for their dedication and sacrifices this year and urged them to continue their battle against COVID-19 by taking a vaccine and sharing their experience with others.
Ahead of a Dec. 17 meeting of its Vaccines and Related Biological Products Advisory Committee, the Food and Drug Administration released a briefing document confirming Moderna’s data on the safety and efficacy of the mRNA-1273 COVID-19 vaccine candidate.
December 15, 2020
An open letter to all health care professionals:
The Centers for Medicare & Medicaid Services recently posted information on how hospitals and other health care providers should bill Medicare for administering COVID-19 vaccines.
The Department of Health and Human Services Dec. 11 announced it would purchase from Moderna 100 million additional doses of its mRNA-1273 COVID-19 vaccine candidate.
Following the Food and Drug Administration’s Dec. 11 emergency use authorization of Pfizer, Inc.’s BNT162b2 mRNA COVID-19 vaccine, AHA released a Special Bulletin with important details for hospitals and health systems.